Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Apple
AAPL
|
$2.91B |
| 2 |
Comcast
CMCSA
|
$1.97B |
| 3 |
Burlington
BURL
|
$1.07B |
| 4 |
Philip Morris
PM
|
$759M |
| 5 |
General Motors
GM
|
$673M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$2.75B |
| 2 |
Netflix
NFLX
|
$1.61B |
| 3 |
Mercado Libre
MELI
|
$1.12B |
| 4 |
Illumina
ILMN
|
$1.05B |
| 5 |
Amazon
AMZN
|
$974M |
Sector Composition
| 1 | Technology | 19.95% |
| 2 | Healthcare | 19.04% |
| 3 | Communication Services | 14.79% |
| 4 | Consumer Discretionary | 12.64% |
| 5 | Industrials | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
CenterPoint Energy
CNP
$24.6B
| $433M | 0.13% | 22,398,382 +12,209,094 | +120% | +$236M |
|
152
Alexandria Real Estate Equities
ARE
$14.1B
| $433M | 0.13% | 2,707,038 -835 | -0% | -$134K |
|
153
NVR
NVR
$22.4B
| $432M | 0.13% | 105,824 +9 | +0% | +$36.7K |
|
154
Integra LifeSciences
IART
$1.18B
| $423M | 0.13% | 8,959,576 -370,870 | -4% | -$17.5M |
|
155
Haemonetics
HAE
$2.63B
| $421M | 0.13% | 4,825,515 +837,512 | +21% | +$73.1M |
|
156
CMS Energy
CMS
$21.4B
| $388M | 0.12% | 6,310,053 +1,149,596 | +22% | +$70.6M |
|
157
Texas Instruments
TXN
$184B
| $386M | 0.12% | 2,705,284 -100,190 | -4% | -$14.3M |
|
158
CrowdStrike
CRWD
$106B
| $384M | 0.12% | 2,795,355 +79,804 | +3% | +$11M |
|
159
Caesars Entertainment
CZR
$5.57B
| $375M | 0.11% | +6,695,535 | New | +$375M |
|
160
Petrobras
PBR
$79.9B
| $368M | 0.11% | 51,733,339 -61,456 | -0.1% | -$438K |
|
|
IPHI
161
DELISTED
INPHI CORPORATION
IPHI
| $365M | 0.11% | 3,249,230 +234,156 | +8% | +$26.3M |
|
|
GWPH
162
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $363M | 0.11% | 3,732,712 +25,050 | +0.7% | +$2.44M |
|
163
Booking.com
BKNG
$181B
| $359M | 0.11% | 209,844 -35,353 | -14% | -$60.5M |
|
164
TopBuild
BLD
$11.8B
| $356M | 0.11% | 2,084,052 -91,376 | -4% | -$15.6M |
|
165
Qorvo
QRVO
$8.4B
| $353M | 0.11% | 2,733,215 +343,924 | +14% | +$44.4M |
|
|
AYX
166
DELISTED
Alteryx, Inc.
AYX
| $351M | 0.11% | 3,087,085 +659,870 | +27% | +$74.9M |
|
167
British American Tobacco
BTI
$124B
| $348M | 0.1% | 9,628,471 -8,470,550 | -47% | -$306M |
|
|
PRAH
168
DELISTED
PRA Health Sciences, Inc.
PRAH
| $347M | 0.1% | 3,422,071 +245,979 | +8% | +$25M |
|
169
Vertex Pharmaceuticals
VRTX
$100B
| $340M | 0.1% | 1,250,658 -1 | -0% | -$272 |
|
170
Cigna
CI
$80.3B
| $333M | 0.1% | 1,965,404 -981,235 | -33% | -$166M |
|
171
Helen of Troy
HELE
$564M
| $331M | 0.1% | 1,710,885 -59,401 | -3% | -$11.5M |
|
172
Johnson & Johnson
JNJ
$427B
| $321M | 0.1% | 2,156,134 -417 | -0% | -$62.1K |
|
173
Advanced Micro Devices
AMD
$264B
| $306M | 0.09% | 3,736,006 -833,087 | -18% | -$68.3M |
|
174
Penumbra
PEN
$10.6B
| $306M | 0.09% | +1,572,825 | New | +$306M |
|
175
Altice USA
ATUS
$1.1B
| $303M | 0.09% | 11,670,715 -680,994 | -6% | -$17.7M |
|